Kisspeptin-10 testing round-up: what our latest samples measured
What the published research on Kisspeptin-10 does and does not establish.
Testing ReportA well-characterised nonapeptide hormone with approved obstetric uses and a large, contested literature on social cognition.
Oxytocin is classified as a nonapeptide hormone. Its current development status is: fda-approved (branded forms). Multiple randomised controlled trials in humans support the primary claims made for this compound.
The Peptide Institute tracks Oxytocin because it is actively sold through research-compound and telehealth channels. Our interest is narrow and specific: what is actually in the vial, whether the label is accurate, and whether the sellers of it can document what they claim. We take no position on whether anyone should use it.
Independent Testing
Every company below was evaluated with product the Institute purchased anonymously and sent for third-party laboratory analysis. Ranked by Index Score™.
97.4% average purity across 1 sample
Purity & Testing 98 Transparency 84 Samples 1 90 View company97.9% average purity across 2 samples
Purity & Testing 87 Transparency 68 Samples 2 79 View company97.7% average purity across 1 sample
Purity & Testing 89 Transparency 52 Samples 1 70 View companyLong-term outcomes with Oxytocin: an open-label extension
Adds to the Oxytocin evidence base without resolving the central question of human efficacy.
Laboratory verification of Oxytocin products across the companies we index.
What the published research on Kisspeptin-10 does and does not establish.
Testing ReportThe Peptide Institute Weekly
One email a week: new study summaries, the latest independent lab results, ranking movements, and regulatory developments that matter.